NHS England

Showing 15 posts of 60 posts found.

nhs_andrew_tatlow

NHS England threatened legal action against Oxford University hospitals trust

April 4, 2019
Medical Communications, Research and Development Hopsitals, NHS, NHS England, OUH, cancer screening, patients

NHS England threatened to sue Oxford University hospitals (OUH) NHS trust after they objected to the former’s controversial decision to …

NHS chief warns of rise of anti-vaccine ‘fake news’ online

March 4, 2019
Sales and Marketing NHS, NHS England, Simon Stevens, anti vaxxer, fake news, vaccines

The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’. …

Data reveals November’s performance was worst on record for NHS

December 14, 2018
Medical Communications NHS, NHS England, UK, funding, investment, wait times

November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …

nhs_sign

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

shutterstock_92671375

UK High Court rejects ABPI’s challenge to new NICE cost curbs

October 5, 2017
Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

HIV-preventing drug to be trialed across England

August 7, 2017
Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …

NHS England takes tough stance on homeopathy

July 24, 2017
Sales and Marketing NHS England, biotech, drugs, pharma, pharmaceutical

Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …

ABPI launches legal action to overturn £20m price cap

July 11, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE

When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …

filing_cabinet

Number of patients at risk from NHS mail mistake revealed

June 27, 2017
Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …

nhs_bands

Cuts to prescriptions aims to save £128 million annually

March 28, 2017
Medical Communications, Research and Development NHS England, prescription

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

nice_reception_small_size

NICE drug expense limit of £20 million could cause treatment delays

March 16, 2017
Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease

NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …

abpi_reception

ABPI welcomes recommendations from NHS specialised services report

April 27, 2016
Research and Development, Sales and Marketing ABPI, NHS, NHS England, NICE, National Audit Office, report, specialised services

The ABPI has welcomed the findings of a National Audit Office report on the commission of specialised service by NHS …

nhs_sign

NHS England approves Cancer Drugs Fund proposals

February 26, 2016
Medical Communications, Research and Development ABPI, Cancer Drugs Fund, NHS England

NHS England has approved proposed reforms of the Cancer Drugs Fund, following the end of the 12-week consultation period earlier …

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016
Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …

The Gateway to Local Adoption Series

Latest content